To identify additional consequences of CHK1 inhibition, we applied reverse-phase protein array (RPPA) pathway activation mapping to monitor the phosphorylation/activation state and/or expression of cancer signaling network proteins (Baldelli et al., 2017). The gene discussed is CHEK1; the disease is cancer.